11 March 2021
Sofitel Legend Amsterdam The Grand
LSP has decided to postpone BioCapital Europe until the 11th March 2021 in light of the growing concerns over the spread of the COVID – 19 virus across Europe and increasing numbers of presenting companies and delegates unable to attend due to corporate travel restrictions.
BioCapital Europe 2020, organised by LSP (Life Sciences Partners) is delighted to announce its 18th consecutive event, taking place on 12th March 2020 in Amsterdam, The Netherlands. For the 9th year running, the event will be held at the luxurious and historic hotel Sofitel Legend The Grand Amsterdam, the former town hall situated in the heart of Amsterdam.
BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe. Attendance is by invitation only. In 2018, the event attracted over 250 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors). VCs and Institutional Investors are invited to attend free of charge to this event.